Literature DB >> 22089375

Mental health disorders and the risk of AIDS-defining illness and death in HIV-infected veterans.

Diana Nurutdinova1, Timothy Chrusciel, Angelique Zeringue, Jeffrey F Scherrer, Ziyad Al-Aly, Jay R McDonald, Edgar T Overton.   

Abstract

OBJECTIVE: Mental health comorbidities are common in HIV-infected veterans and can impact clinical outcomes for HIV. We examined the impact of mental health diagnoses on progression to AIDS-defining illness (ADI) and death in a large cohort of HIV-infected veterans who accessed care between 2001 and 2006.
DESIGN: Retrospective cohort study using the national Veterans Health Administration (VHA) HIV Clinical Case Registry.
METHODS: We identified HIV-infected veterans initiating combination antiretroviral therapy (cART) within the VHA between 2000 and 2006. The prevalences of the following mental health diagnoses were examined: schizophrenia, bipolar disorder, depression, anxiety, and substance use disorder. Cox proportional hazards models were constructed to examine the relationship between mental health conditions and two outcomes, all-cause mortality and ADI. Models were computed before and after adjusting for confounding factors including age, race, baseline CD4 cell count, comorbidities and cART adherence.
RESULTS: Among 9003 veterans receiving cART, 31% had no mental health diagnosis. Age, race, baseline comorbidity score, CD4, and cART adherence were associated with shorter time to ADI or death. All-cause mortality was more likely among veterans with schizophrenia, bipolar disorder and substance use, and ADI was more likely to occur among veterans with substance use disorder.
CONCLUSIONS: Our results demonstrate the high prevalence of mental health diagnoses among HIV-infected veterans. In the era of highly active antiretroviral therapy, presence of psychiatric diagnoses impacted survival and development of ADI. More aggressive measures addressing substance abuse and severe mental illness in HIV-infected veterans are necessary.

Entities:  

Mesh:

Year:  2012        PMID: 22089375     DOI: 10.1097/QAD.0b013e32834e1404

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  21 in total

Review 1.  Neuropsychiatric complications of aging with HIV.

Authors:  Crystal C Watkins; Glenn J Treisman
Journal:  J Neurovirol       Date:  2012-05-30       Impact factor: 2.643

2.  Frailty and Pre-Frailty in a Contemporary Cohort of HIV-Infected Adults.

Authors:  N F Önen; P Patel; J Baker; L Conley; J T Brooks; T Bush; K Henry; J Hammer; E M Kojic; E T Overton
Journal:  J Frailty Aging       Date:  2014

3.  Depression and all-cause mortality risk in HIV-infected and HIV-uninfected US veterans: a cohort study.

Authors:  K So-Armah; S K Gupta; S Kundu; J C Stewart; J L Goulet; A A Butt; J J Sico; V C Marconi; S Crystal; M C Rodriguez-Barradas; M Budoff; C L Gibert; C-Ch Chang; R Bedimo; M S Freiberg
Journal:  HIV Med       Date:  2019-03-29       Impact factor: 3.180

4.  Pain is independently associated with impaired physical function in HIV-infected patients.

Authors:  Jessica S Merlin; Andrew O Westfall; Eric Chamot; E Turner Overton; James H Willig; Christine Ritchie; Michael S Saag; Michael J Mugavero
Journal:  Pain Med       Date:  2013-10-09       Impact factor: 3.750

5.  Implementing electronic substance use disorder and depression and anxiety screening and behavioral interventions in primary care clinics serving people with HIV: Protocol for the Promoting Access to Care Engagement (PACE) trial.

Authors:  Derek D Satre; Alexandra N Anderson; Amy S Leibowitz; Tory Levine-Hall; Sally Slome; Jason Flamm; C Bradley Hare; Jennifer McNeely; Constance M Weisner; Michael A Horberg; Paul Volberding; Michael J Silverberg
Journal:  Contemp Clin Trials       Date:  2019-08-22       Impact factor: 2.226

6.  Is serious mental illness associated with earlier death among persons with HIV? Ten year follow up in Maryland Medicaid Recipients.

Authors:  Geetanjali Chander; YiYi Zhang; Susan dosReis; Donald M Steinwachs; Daniel E Ford; Eliseo Guallar; Gail Daumit
Journal:  J AIDS HIV Res       Date:  2012-08

7.  Relationship between ever reporting depressive symptoms and all-cause mortality in a cohort of HIV-infected adults in routine care.

Authors:  Angela M Bengtson; Brian W Pence; Richard Moore; Matthew J Mimiaga; William Christopher Mathews; Amy Heine; Bradley N Gaynes; Sonia Napravnik; Katerina Christopoulos; Heidi M Crane; Michael J Mugavero
Journal:  AIDS       Date:  2017-04-24       Impact factor: 4.177

8.  Factors associated with treatment initiation for psychiatric and substance use disorders among persons with HIV.

Authors:  Derek D Satre; Gerald N DeLorenze; Charles P Quesenberry; Ailin Tsai; Constance Weisner
Journal:  Psychiatr Serv       Date:  2013-08-01       Impact factor: 3.084

9.  Documentation of psychiatric disorders and related factors in a large sample population of HIV-positive patients in California.

Authors:  Iman Parhami; Timothy W Fong; Aaron Siani; Claudia Carlotti; Homayoon Khanlou
Journal:  AIDS Behav       Date:  2013-10

10.  Use of Nonantiretroviral Medications That May Impact Neurocognition: Patterns and Predictors in a Large, Long-Term HIV Cohort Study.

Authors:  Kendra K Radtke; Peter Bacchetti; Kathryn Anastos; Daniel Merenstein; Howard Crystal; Roksana Karim; Kathleen M Weber; Andrew Edmonds; Anandi N Sheth; Margaret A Fischl; David Vance; Ruth M Greenblatt; Leah H Rubin
Journal:  J Acquir Immune Defic Syndr       Date:  2018-06-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.